Overview
This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.
Description
The intervention involves a set of tested intervention messages, ecological momentary assessments (EMAs), and e-diary entries to our PsyMINT mobile app. A 1-week mHealth intervention to cancer survivors who experience pain will be delivered. The feasibility of an mHealth app platform (PsyMINT) as a message presentation environment will be delivered and evaluated. The app messages will target five topics/modules, including psychoeducational materials related to pain management; positive psychology; opioid literacy; skill building for patient-provider communication and trust; and quality of life.
Eligibility
Inclusion Criteria:
- In a post-treatment stage with no evidence of disease (complete remission)
- Diagnosed with cancer in the past three years
- Experiencing cancer/treatment-related pain
- ≥ 18 years of age at the time of first diagnosis
- Cognitively able to actively participate in an online-based study
- Able to read, write, and understand English
Exclusion Criteria:
- Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers)
- Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders.
- Those who are currently pregnant or plan to become pregnant in the next three months
